发明名称 PIPERIDINE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS
摘要 <p>The present invention relates to a compound of formula (I): wherein: V and U are hydrogen, halogen, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkylamino, or together form a group that contains one or more heteroatoms, and that taken together with one or more: (a) hydrogen atoms; (b) carbon atoms; (c) -CH- groups; (d) -CH&lt;SUB&gt;2&lt;/SUB&gt;- groups; or (e) additional heteroatoms of the same or different type; or any combination thereof, form a 4-7 membered homocyclic or heterocyclic ring, wherein the homocyclic or heterocyclic ring may combine with the phenyl group to form a bicyclic ring, and wherein the homocyclic or heterocyclic ring or the bicyclic ring may contain one or more oxo, thioxo, amino, mercapto, trifluoromethyl, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkyl, -S or -SH groups; W: is -CO-, -CH&lt;SUB&gt;2&lt;/SUB&gt;- or -CH&lt;SUB&gt;2&lt;/SUB&gt;-(C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkyl)-; X: is -CO-; Y: is -O-, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkylene, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkynylene, cycloalkylene, aminocarbonyl, -NH-, -N(C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkyl)-, -C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkylene-N(C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkyl)-, -CH&lt;SUB&gt;2&lt;/SUB&gt;O-, -CH(OH)- or -OCH&lt;SUB&gt;2&lt;/SUB&gt;-; Z: is hydrogen, halogen, nitro, amino, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkyl, C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;4 &lt;/SUB&gt;alkoxy, cyano, trifluoromethyl, hydroxyl or carboxyl; R&lt;SUP&gt;1 &lt;/SUP&gt;and R&lt;SUP&gt;2&lt;/SUP&gt;: are hydrogen, or together form a C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;3 &lt;/SUB&gt;bridge; and n and m: independently are 0-3, wherein n and m cannot each be 0; or an optical antipode, racemate or pharmaceutically-acceptable salt thereof. The carboxylic acid amide derivatives of formula (I) are highly effective and selective antagonists of the NMDA receptor.</p>
申请公布号 EP1409477(B1) 申请公布日期 2008.09.17
申请号 EP20020753161 申请日期 2002.07.23
申请人 RICHTER GEDEON NYRT 发明人 DOMANY, GYOERGY;HORVATH, CSILLA;FARKAS, SANDOR;BARTANE SZALAI, GIZELLA;NAGY, JOZSEF;KOLOK, SANDOR;BOZO, EVA;BORZA, ISTVAN;VAGO, ISTVAN;BIELIK, ATTILA;IGNACZNE SZENDREI, GYOERGYI;KESERUE, GYOERGY
分类号 C07D401/12;A61K;A61K31/445;A61K31/454;A61K31/4545;A61K31/46;A61K31/4709;A61P;A61P3/10;A61P9/00;A61P11/06;A61P21/00;A61P21/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P31/12;A61P31/18;A61P43/00;C07D;C07D211/14;C07D211/16;C07D211/18;C07D295/185;C07D401/06;C07D407/12;C07D413/12;C07D417/12;C07D451/02 主分类号 C07D401/12
代理机构 代理人
主权项
地址